Changes in prevalence of problem opiate use in Germany between 1990 and 2000

European Addiction Research

Volumn 10, Issue 2, 2004, Pages 61-67

  Augustin, Rita ^a   Kraus, Ludwig ^a  

^a IFT INSTITUT FÜR THERAPIEFORSCHUNG   (Germany)

Author keywords

Multiplier method; Prevalence estimation; Problem opiate use

Indexed keywords

DIAMORPHINE;

ARTICLE; CALCULATION; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG USE; GERMANY; HUMAN; MONITORING; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SAMPLING; STATISTICAL ANALYSIS;

GERMANY; HUMANS; OPIOID-RELATED DISORDERS; POLICE; PREVALENCE; TREATMENT OUTCOME;

EID: 1542408532     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076115     Document Type: Article

References (31)

1. Pohlisch K: Die Verbreitung des chronischen Opiatmissbrauchs in Deutschland. Dtsch Med Wochenschr 1931;47:1984-1986.
2. Skarabis H, Becker BM, Patzak H: Epidemiologische Untersuchung zur Schätzung des Umfangs und der Sozialstruktur der Heroinszene in Berlin (West). Berl Ärztekammer 1980;20:1-10.
3. Grünbeck P, Markert S, Tielmann F: Prävalenz des Konsums harter Drogen. Eine Schätzung zum Umfang der Berliner Opiatszene. AZ Hefte, Aids Zentrum im Bundesgesundheitsamt, 1994, vol 21.
4. Kirschner W: Case-finding, capture-recapture and double counting: A Berlin case study; in Stimson G, Hickman M, Quirk A, Frischer M (eds): Estimating the Prevalence of Problem Drug Use in Europe. Scientific Monograph Series No 1. Luxembourg, European Communities, 1997, pp 215-224.
5. Kirschner W, Kunert M: Umfang und Struktur von i.v. Drogenabhä ngigen in Deutschland (1995). Anonymes Monitoring in den Praxen niedergelassener Ärzte. Munich, Profil, 1997.
6. Klingemann H, Goos C, Hartnoll R, Jablensky A, Rehm J: European Summary on Drug Abuse. Copenhagen, WHO Regional Office for Europe, 1991.
7. IFT Institut für Therapieforschung, München, Institut für Rechtsmedizin, Universität Hamburg and Bundeskriminalamt Wiesbaden: Report on the Methods of Estimating the Extent of the Drug Problem in Germany. IFT-Bericht. Munich, Institut für Therapieforschung, 1994, vol 71.
8. Bühringer G, Adelsberger F, Heinemann A, Kirschner W, Knauss I, Kraus L, Püschel K, Simon R: Schätzverfahren und Schätzungen 1997 zum Umfang der Drogenproblematik in Deutschland. Sucht 1997;43(suppl 2).
9. Kraus L, Shaw R, Augustin R, Ritz F: Analyse der Drogentodesfälle in Bayern. IFT-Berichte. Munich, IFT Institut für Therapieforschung, 2001, vol 116.
10. Kraus L, Ladwig A: Analyse der Drogentodesfälle in Baden-Württemberg. IFT-Berichte. Munich, IFT Institut für Therapieforschung, 2001, vol 123.
11. Stimson G, Hickman M, Quirk A, Frischer M: Estimating the Prevalence of Problem Drug Use in Europe. Scientific Monograph Series No 1. Luxembourg, European Communities, 1997.
12. Welsch K: Suchthilfestatistik 2000. Sucht 2001;47(suppl 3).
13. Kraus L: National prevalence estimation: Selecting appropriate methods in a country; in Stimson G, Hickman M, Quirk A, Frischer M (eds): Estimating the Prevalence of Problem Drug Use in Europe. Scientific Monograph Series No 1. Luxembourg, European Communities, 1997, pp 191-198.
14. Frischer M, Goldberg D, Taylor A, Bloor M: Estimating the incidence and prevalence of injecting drug use in Glasgow. Addict Res 1997;5:307-315.
15. Costes JM: France: Country report; in Kraus L, Augustin R, Kümmler P, Wiessing L, Hartnoll R (eds): Study to Obtain Comparable National Estimates of Problem Drug Use Prevalence for all EU Member States. Annex I. Lisbon, European Monitoring Centre for Drugs and Drug Addiction, 1999, pp 1-11.
16. Mariani F: Italy: Country report; in Kraus L, Augustin R, Kümmler P, Wiessing L, Hartnoll R (eds): Study to Obtain Comparable National Estimates of Problem Drug Use Prevalence for all EU Member States. Annex I. Lisbon, European Monitoring Centre for Drugs and Drug Addiction, 1999, pp 1-21.
17. Origer A: Estimation de la prévalence nationale de l'usage problématique de drogues à risque élevé et d'acquisition illicite - Etude comparative multi-méthodes 1997-2000, séries de recherche No 2. Luxembourg, Point focal OEDT Luxembourg - CRP-Santé, 2001.
18. Kraus L, Beloch E, Qammou-Engel M, Müller-Kalthoff T: Verbesserung der therapeutischen Situation für Drogenkonsumenten in Augsburg unter besonderer Berücksichtigung von Massnahmen zur Reduzierung der Zahl der Todesfälle. IFT-Berichte. Munich, IFT Institut für Therapieforschung, 2001, vol 119.
19. Raschke P, Püschel K, Heinemann A: Rauschgiftmortalität und Substitutionstherapie in Hamburg (1990-1998). Suchttherapie 2000;1:43-48.
20. Frischer M, Hickman M, Kraus L, Mariani F, Wiessing L: A comparison of different methods for estimating the prevalence of problematic drug use in Great Britain. Addiction 2001;96:1465-1476.
21. Bundeskriminalamt Rauschgiftjahresbericht 2001: Bundesrepublik Deutschland. Wiesbaden, Bundeskriminalamt, 2001 (http://www. bka.de).
22. Korf D: Comparison of different estimation methods in the Netherlands; in Stimson G, Hickman M, Quirk A, Frischer M (eds): Estimating the Prevalence of Problem Drug Use in Europe. Scientific Monograph Series No 1. Luxembourg, European Communities, 1997, pp 199-214.
23. Stoever H: Consumption rooms - A middle ground between health and public order concerns. J Drug Issues 2002;32:597-606.
24. Warner-Smith M, Darke S, Lynskey M, Hall W: Heroin overdose: Causes and consequences. Addiction 2001;96:1113-1125.
25. Degenhardt L, Lynskey M, Hall W: Cohort trends in age of initiation of drug use in Australia. Aust NZ J Public Health 2000;24:421-426.
26. Lynsky M, Hall W: Cohort trends in age of initiation to heroin use. Drug Alcohol 1998;17:289-297.
27. International Working Group for Disease Monitoring and Forecasting: Capture-recapture and multiple-record systems estimation. II. Applications in human diseases. Am J Epidemiol 1995;142:1059-1068.
28. Godfrey C, Wiessing L, Hartnoll R: Modelling drug use: Methods to quantify and understand hidden processes. Scientific Monograph Series No 6. Luxembourg, European Communities, 2001.
29. Rhodes W: Synthetic estimation applied to the prevalence of drug use. J Drug Issues 1993;23:297-322.
30. Wickens TD: Quantitative methods for estimating the size of a drug-using population. J Drug Issues 1993;23:185-216.
31. Kraus L, Augustin R, Frischer M, Kümmler P, Uhl A, Wiessing L: Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction 2003;98:471-485.